BFA Logo Transparent (002).png
ME INVESTIGATION NOTICE: The Investigation into 23andMe Holding Co. is Ongoing – Contact BFA Law if You are a Current Shareholder (Nasdaq:ME)
September 27, 2024 06:16 ET | Bleichmar Fonti & Auld
23andMe Holding Co. shareholders are encouraged to contact BFA Law about its investigation into the Board for breaches of fiduciary duties.
BFA Logo Transparent (002).png
FIVE MONDAY DEADLINE: The September 30 Court Deadline in the Five Below, Inc. Class Action is Approaching – Contact BFA Law if You Suffered Losses (Nasdaq:FIVE)
September 27, 2024 06:16 ET | Bleichmar Fonti & Auld
Five Below, Inc. investors that lost money on their investment are encouraged to contact BFA Law before September 30, 2024 legal deadline.
BFA Logo Transparent (002).png
EXTR FRAUD NOTICE: The October 15 Court Deadline in the Extreme Networks, Inc. Class Action is Approaching – Contact BFA Law if You Suffered Losses (Nasdaq:EXTR)
September 27, 2024 06:16 ET | Bleichmar Fonti & Auld
Extreme Networks, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 15, 2024 legal deadline.
BFA Logo Transparent (002).png
SMCI FRAUD UPDATE: The Justice Department is Investigating Super Micro Computer; Investors who Lost Money are Encouraged to Contact BFA Law about Class Action (Nasdaq:SMCI)
September 27, 2024 06:16 ET | Bleichmar Fonti & Auld
Super Micro Computer investors that lost money on their investment are encouraged to contact BFA Law before the October 29, 2024 legal deadline.
BFA Logo Transparent (002).png
DXCM FRAUD NOTICE: The October 21 Court Deadline in the DexCom, Inc. Class Action is Approaching – Contact BFA Law if You Suffered Losses (Nasdaq:DXCM)
September 27, 2024 06:16 ET | Bleichmar Fonti & Auld
DexCom, Inc. investors that lost money on their investment are encouraged to contact BFA Law before October 21, 2024 legal deadline.
22157.jpg
OTC Drug & Dietary Supplement Market Assessment (2018-2030) Featuring Strategic Analysis of Johnson & Johnson, Pfizer, Sanofi, Roche, AstraZeneca & More - A $256 Billion Industry Opportunity
September 27, 2024 06:13 ET | Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "OTC Drug & Dietary Supplement Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
22157.jpg
Germany Construction Industry Report 2024: Output to Register an AAGR of 2.4% During 2025-2028, Supported by Investments in Transport Infrastructure, and Renewable Energy
September 27, 2024 06:10 ET | Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Germany Construction Market Size, Trends, and Forecasts by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and...
22157.jpg
Turkey Construction Industry Report 2024: Output to Grow by 5.4% in Real-terms this Year, Supported by Rising Building Approvals, Coupled with PPI in Industrial and Energy - Forecast to 2028
September 27, 2024 06:08 ET | Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Turkey Construction Market Size, Trends, and Forecasts by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and...
22157.jpg
Lithuania Construction Industry Report 2024: Output to Shrink by 1.3% in Real-terms this Year Before a Projected AAGR of 3.8% During 2025-2028
September 27, 2024 06:05 ET | Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Lithuania Construction Market Size, Trends, and Forecasts by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional and...
111Boehringer_Ingelheim_Logo_RGB_Dark_Green (002).png
Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities
September 27, 2024 06:05 ET | Boehringer Ingelheim
Boehringer Ingelheim has entered a partnership with the NCD Alliance, a network dedicated to shaping a world in which everyone can live a healthy and productive life, free from the preventable...